Prolonged sedation in Intensive Care Units;Sedación prolongada en Unidades de Cuidados Intensivos

Medicina Intensiva

Volumn 32, Issue SUPPL. 1, 2008, Pages 19-30

  Estebanez Montiel M B ^a   Alonso Fernandez M A ^a   Sandiumenge, A ^b   Jimenez Martin M J ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Daily sedation interruption; Dynamic sedation; Long term sedation; Sequential sedation

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; KETAMINE; MIDAZOLAM; PROPOFOL; REMIFENTANIL; SEDATIVE AGENT;

ANALGESIA; ANALGESIC ACTIVITY; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; HUMAN; INTENSIVE CARE UNIT; PATIENT MONITORING; REVIEW; SEDATION; TREATMENT DURATION;

DEEP SEDATION; HUMANS; INTENSIVE CARE UNITS; TIME FACTORS;

EID: 45749107617     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Nasraway SA, Jacobi J, Murray MJ, Lumb PD; Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine and the American Society of Health-System Parmacists, American College of Chest Physicians. Sedation, analgesia, and neuromuscular blockade of the critically ill adult: revised clinical practice guidelines for 2002. Crit Care Med. 2002;30:117-8.
2. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al; Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine and the American Society of Health-System Parmacists, American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-41.
3. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the Intensive Care Unit. A systematic review. JAMA. 2000;283:1451-9.
4. Sánchez-Izquierdo Riera JA, Alted López E, Sa Borges M, Sandiumenge A. Sedoanalgesia-relajación en una Unidad de Cuidados Intensivos. Situación en España. Med Intensiva. 1998;22:1-6.
5. Blackburn P, Vissers R. Pharmacology of emergency Department pain management and conscious sedation. Emerg Med Clin North Am. 2000;18:803-27.
6. Liu LL, Gropper MA. Postoperative analgesia and sedation in the adult Intensive Care Unit. Drugs. 2003;63:755-67.
7. Chamorro C, Romera MA, Silva JA. Importancia de la sedoanalgesia en los pacientes en ventilación mecánica. Med Intensiva. 2003;1 Supl:2-4.
8. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care. 2006;10:R91-9.
9. Weinbroum AA, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med. 1997;23:1258-63.
10. Barrientos-Vega R, Sánchez-Soria MM, Morales-García C, Robas-Gómez A, Cuenca-Boy R, Ayensa-Rincón A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med. 1997;25:33-40.
11. Sánchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Pérez-Vela JL, Ambros-Checa A, Cantalapiedra-Santiago JA, Alted-López E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg. 1998;86:1219-24.
12. Chamorro C, De Latorre FJ, Montero A, Sánchez-Izquierdo JA, Jareño A, Moreno JA, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med. 1996;24:932-9.
13. Sandiumenge Camps A, Sánchez-Izquierdo Riera JA, Toral Vázquez D, Sa Borges M, Peinado Rodríguez J, Alted López E. Midazolam and 2% propofol in long-term sedation of traumatized critically ill patients: efficacy and safety comparison. Crit Care Med. 2000;28:3612-9.
14. Hall RI, Sandham D, Cardinal P, Tweeddale M, Moher D, Wanq X, et al; Study Investigators. Propofol vs midazolam for ICU sedation. A Canadian Multicenter Randomized Trial. Chest. 2001;119:1151-9.
15. Swart EL, van Schijndel RJM, van Loenen AC, Lambertus G. Continuous of lorazepam versus midazolam in patients in the intensive care unit: Sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med. 1999;27:1461-5.
16. Carrasco G, Molina R, Costa J, Soler JM, Cabré L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest. 1993;103:557-64.
17. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338-44.
18. Ely EW, Truman B, Shintani A, Thomnason JW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289:2983-91.
19. Chamorro C, Romera MA, Martínez JL. Sedación y analgesia de pacientes críticos en ventilación mecánica. ¿Tienen utilidad los alfa-2 agonistas? Med Intensiva. 1999;23:59-61.
20. Castañeda J. Farmacocinética y farmacodinámica del remifentanilo. Med Intensiva. 2003;27 Supl 1:10-3.
21. Mattia C, Savoia G, Paoletti F, Piazza O, Albanese D, Amantea B, et al; SIAARTI. SIAARTI recommendations for analgo-sedation in intensive care unit. Minerva Anestesiol. 2006;72:769-805.
22. Palazón C, Palazón E, Pardo JC, Blanco T, Gómez MJ, López J, et al. Estudio comparativo de la efectividad y calidad de sedoanalgesia en pacientes ventilados mecánicamente. Med Intensiva. 1999;23:416-20.
23. Shelly MP, Sultan MA, Bodenham A, Park GR. Midazolam infusions in critically ill patients. Eur J Anaesthesiol. 1991;8:21-7.
24. Natheson G, Goleen GS, Litt IF. Diazepam in the management of the neonatal narcotic withdrawal syndrome. Pediatrics. 1971;48:523-7.
25. Chamorro C, Romera MA, Pardo C. Analgesia y sedación del paciente crítico. Presente y futuro. Med Intensiva. 2004;28 Supl 3:1-4.
26. Chamorro C. Reflexiones sobre Sedoanalgesia y Bloqueo Neuromuscular: el "Top Ten" de lo publicado. En: Nuevas evidencias en Sedoanalgesia y Bloqueo Neuromuscular: XLI Congreso Nacional de la SEMICYUC. Pamplona; 2006. p. 8-14.
27. Knibbe CAJ, Naber H, Aarts LPHJ, Kuks PFM, Danhof M. Long-term sedation with propofol 60 mg/ml vs. propofol 10 mg/ml in critically ill, mechanically ventilated patients. Acta Anaesthesiol Scand. 2004;48:302-7.
28. Cremer OL, Moons KGM, Bouman EAC, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117-8.
29. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417-25.
30. Riker RR, Gilles LF, Pharm D. Adverse effects associated with sedatives, analgesics, and other drugs that provide patient confort in the Intensive Care Unit. Phamacotherapy. 2005;25:8S-18S.
31. Barrientos-Vega R, Sánchez Soria MM, Morales García C, Cuenca Boy R, Castellano Hernández M. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med. 2001;29:317-22.
32. Manley NM, Fitzpatrick RW, Long T, Jones PW. A cost analysis of alfentanil + propofol vs. morphine + midazolam for the sedation of critically ill patients. Pharmacoeconomics. 1997;12: 247-55.
33. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med. 1994;22:1241-7.
34. Kolenda H, Gremmelt A, Rading S, Braun U, Markakis E. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir. 1996;138:1193-9.
35. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL, et al. Decreased duration of mechanical ventilation when comparating analgesia-based sedation using remifentanil with standard hipnotic-based sedation for up to 10 days in intensive care unit patients: a randomized trial. Crit Care. 2005;9:R200-10.
36. Epstein J, Breslow MJ. The stress response of critical illness. Crit Care Clin. 1999;15:17-33.
37. Fraser GL, Prato BS, Riker RR, Berthiaume D, Wilkins ML, et al. Evaluation of agitation in ICU patients: Incidence, severity, and treatment in the young versus the elderly. Phamacotherapy. 2000;20:75-82.
38. Treggiari-Venzi M, Borgeat A, Fuchs-Buder T, Gachoud JP, Suter PM. Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression. Intensive Care Med. 1996;22:1186-90.
39. Fraser GL, Riker RR, Prato S, Wilkins MS. The frequency and cost of patient-initiated decice removal in the ICU. Pharmacotherapy. 2001;21:1-6.
40. Kress JP, Hall JB. Sedation in the mechanically ventilated patient. Crit Care Med. 2006;34:2541-6.
41. Schweickert W, Gehlbach B, Pohlman A, Hall J, Kress J. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med. 2004;32:1272-6.
42. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous iv sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541-8.
43. Schelling G, Stoll C, Haller M, Briegel J, Manert W, Hummel T, et al. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med. 1998;26:651-9.
44. Granja C, Lopes A, Moreira S, Dias C, Costa-Pereira A, Carneiro A, for the JMIP Study Group. Patients' recollections of experiences in the intensive care unit may affect their quality of life. Crit Care. 2005;9:R96-109.
45. Hough Cl, Curtis JR. Long-term sequelae of critical illness: memories and health-related quality of life. Crit Care. 2005;9:145-6.
46. Jones C, Griffiths RD, Humphris G, Skirrow PM. Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med. 2001;29:573-80.
47. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998;26:676-84.
48. Ista E, Van Dijk M, Gamel C, Tibboel D, De Hoog M. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. "Assessment remains troublesome". Intensive Care Med. 2007;33:1396-1406.
49. Brown C, Albrecht R, Pettit H, McFadden T, Schermer C. Opioid and benzodiazepine withdrawal syndrome in adult burn patients. Am Surg. 2000;66:367-71.
50. Korak-Leiter M, Likar R, Oher M, Trampitsch E, Ziervogel G, Levy JV, et al. Withdrawal following sufentanil/propofol and sufentanil/midazolam sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids. Intensive Care Med. 2005;31:380-7.
51. Au J, Walker W, Scott D. Withdrawal syndrome after propofol infusion. Anaesthesia. 1990;45:741-2.
52. Masataka S, Yoshiaki T, Makoto F, Tetsuji M, Osamu S, Koji S. Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients. Anesth Analg. 2003;96:834-8.
53. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286:2703-10.
54. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-7.
55. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27:2609-15.
56. Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault PF, et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med. 2006;34:1691-9.
57. Pardo C, Muñoz T, Chamorro C, Grupo de Trabajo de Analgesia y Sedación de la SEMICYUC. Monitorización del dolor. Recomendaciones del grupo de trabajo de analgesia y sedación de la SEMICYUC. Med Intensiva. 2006;30:379-85.
58. De Jonghe B, Bastuji-Garin S, Fangio P, Lacherade JC, Jabot J, Appéré-De-Vecchi C, et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med. 2005;33:120-7.
59. Park G, Lane M, Rogers S, Bassett P. A comparison of hypnotic and analgesic based sedation in a general intensive care unit. Br J Anaesth. 2007;98:76-82.
60. Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients. A randomized double blind study. Anestesiology. 2004;101:640-6.
61. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care. 2006;10:91.